YARROW BIOSCIENCE, INC. Increase (Decrease) in Other Noncurrent Assets
YARROW BIOSCIENCE, INC. (YARW) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2023-03-14
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent assets for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent assets for the quarter ending 2022-09-30 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent assets for the quarter ending 2022-06-30 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent assets for the quarter ending 2022-03-31 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was $0.00.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent assets for fiscal 2021 was -$841.00K, a 120.16% decline from fiscal 2020.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent assets for fiscal 2020 was $4.17M, a 3083.97% increase from fiscal 2019.
- YARROW BIOSCIENCE, INC. increase (decrease) in other noncurrent assets for fiscal 2019 was $131.00K, a 835.71% increase from fiscal 2018.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 3 month as first filed | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | $0.00 derived: sum of 3 quarters · filed 2023-03-14 | $0.00 10-K · filed 2023-03-14 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | $376.00K derived: sum of 4 quarters · filed 2023-03-14 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $376.00K derived: sum of 3 quarters · filed 2023-03-14 | $35.00K derived: sum of 4 quarters · filed 2023-03-14 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | $376.00K derived: sum of 2 quarters · filed 2023-03-14 | $35.00K derived: sum of 3 quarters · filed 2023-03-14 | -$437.00K derived: sum of 4 quarters · filed 2023-03-14 | ||
| 2021-12-31 | $376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $35.00K derived: sum of 2 quarters · filed 2023-03-14 | -$437.00K derived: sum of 3 quarters · filed 2023-03-14 | -$841.00K 10-K · filed 2023-03-14 | ||
| 2021-09-30 | -$341.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$813.00K derived: sum of 2 quarters · filed 2022-11-14 | -$1.22M 10-Q · filed 2022-11-14 | -$1.48M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$472.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$876.00K 10-Q · filed 2022-08-12 | -$1.14M derived: sum of 3 quarters · filed 2022-08-12 | -$2.73M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | -$404.00K 10-Q · filed 2022-05-12 | -$663.00K derived: sum of 2 quarters · filed 2022-05-12 | -$2.26M derived: sum of 3 quarters · filed 2022-05-12 | $740.00K derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$1.85M derived: sum of 2 quarters · filed 2022-03-17 | $1.14M derived: sum of 3 quarters · filed 2022-03-17 | $4.17M 10-K · filed 2022-03-17 | ||
| 2020-09-30 | -$1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.40M derived: sum of 2 quarters · filed 2021-11-10 | $4.43M 10-Q · filed 2021-11-10 | $4.44M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $6.03M 10-Q · filed 2021-08-12 | $6.03M derived: sum of 3 quarters · filed 2021-08-12 | $6.16M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $3.03M 10-Q · filed 2021-05-06 | $3.03M derived: sum of 2 quarters · filed 2021-05-06 | $3.16M derived: sum of 3 quarters · filed 2021-05-06 | $3.15M derived: sum of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $131.00K derived: sum of 2 quarters · filed 2021-03-04 | $127.00K derived: sum of 3 quarters · filed 2021-03-04 | $131.00K 10-K · filed 2021-03-04 | -$209.00K 10-K · filed 2020-03-03 | |
| 2019-09-30 | $124.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $120.00K derived: sum of 2 quarters · filed 2020-11-05 | $124.00K 10-Q · filed 2020-11-05 | -$216.00K derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2019-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | -$340.00K derived: sum of 3 quarters · filed 2021-03-04 | -$292.00K derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2019-03-31 | $4.00K 10-Q · filed 2020-05-11 | -$59.00K 10-Q · filed 2019-05-02 | -$336.00K derived: sum of 2 quarters · filed 2021-03-04 | -$288.00K derived: sum of 3 quarters · filed 2021-03-04 | -$67.00K derived: sum of 4 quarters · filed 2021-03-04 | |
| 2018-12-31 | -$340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$292.00K derived: sum of 2 quarters · filed 2021-03-04 | -$71.00K derived: sum of 3 quarters · filed 2021-03-04 | $14.00K 10-K · filed 2021-03-04 | $282.00K 10-K · filed 2019-02-28 | |
| 2018-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $269.00K derived: sum of 2 quarters · filed 2018-11-07 | $354.00K 10-Q · filed 2018-11-07 | $354.00K derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2018-06-30 | $221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $306.00K 10-Q · filed 2018-08-01 | $306.00K derived: sum of 3 quarters · filed 2020-03-03 | $306.00K derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2018-03-31 | $85.00K 10-Q · filed 2019-05-02 | $85.00K derived: sum of 2 quarters · filed 2020-03-03 | $85.00K derived: sum of 3 quarters · filed 2020-03-03 | $85.00K derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $0.00 derived: sum of 2 quarters · filed 2020-03-03 | $0.00 derived: sum of 3 quarters · filed 2020-03-03 | -$66.00K 10-K · filed 2020-03-03 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | -$66.00K 10-Q · filed 2018-11-07 | |||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$66.00K 10-Q · filed 2018-08-01 | ||||
| 2017-03-31 | -$66.00K 10-Q · filed 2018-05-09 | |||||
| 2016-12-31 | $66.00K 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |